Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 68
Filter
1.
Ann Neurol ; 90(2): 319-323, 2021 08.
Article in English | MEDLINE | ID: mdl-34180078

ABSTRACT

We here describe the identification of a novel variant in the anti-inflammatory Annexin A1 protein likely to be the cause of disease in two siblings with autosomal recessive parkinsonism. The disease-segregating variant was ascertained through a combination of homozygosity mapping and whole genome sequencing and was shown to impair phagocytosis in zebrafish mutant embryos. The highly conserved variant, absent in healthy individuals and public SNP databases, affected a functional domain of the protein with neuroprotective properties. This study supports the hypothesis that damaged microglia might lead to impairments in the clearance of accumulated and aggregated proteins resulting in parkinsonism. ANN NEUROL 2021;90:319-323.


Subject(s)
Annexins/genetics , Genetic Variation/genetics , Parkinsonian Disorders/diagnosis , Parkinsonian Disorders/genetics , Animals , Female , Humans , Inflammation/diagnosis , Inflammation/genetics , Middle Aged , Pedigree , Siblings , Zebrafish
4.
Sci Rep ; 10(1): 968, 2020 01 22.
Article in English | MEDLINE | ID: mdl-31969655

ABSTRACT

Intellectual disability (ID), which presents itself during childhood, belongs to a group of neurodevelopmental disorders (NDDs) that are clinically widely heterogeneous and highly heritable, often being caused by single gene defects. Indeed, NDDs can be attributed to mutations at over 1000 loci, and all type of mutations, ranging from single nucleotide variations (SNVs) to large, complex copy number variations (CNVs), have been reported in patients with ID and other related NDDs. In this study, we recruited seven different recessive NDD families with comorbidities to perform a detailed clinical characterization and a complete genomic analysis that consisted of a combination of high throughput SNP-based genotyping and whole-genome sequencing (WGS). Different disease-associated loci and pathogenic gene mutations were identified in each family, including known (n = 4) and novel (n = 2) mutations in known genes (NAGLU, SLC5A2, POLR3B, VPS13A, SYN1, SPG11), and the identification of a novel disease gene (n = 1; NSL1). Functional analyses were additionally performed in a gene associated with autism-like symptoms and epileptic seizures for further proof of pathogenicity. Lastly, detailed genotype-phenotype correlations were carried out to assist with the diagnosis of prospective families and to determine genomic variation with clinical relevance. We concluded that the combination of linkage analyses and WGS to search for disease genes still remains a fruitful strategy for complex diseases with a variety of mutated genes and heterogeneous phenotypic manifestations, allowing for the identification of novel mutations, genes, and phenotypes, and leading to improvements in both diagnostic strategies and functional characterization of disease mechanisms.


Subject(s)
Genetic Variation , Genotype , Intellectual Disability/genetics , Phenotype , DNA Copy Number Variations , Female , Genetic Association Studies , Humans , Male , Mutation , Pedigree , Polymorphism, Single Nucleotide
5.
Life Sci Alliance ; 3(2)2020 02.
Article in English | MEDLINE | ID: mdl-31882397

ABSTRACT

We identified a consanguineous kindred, of three affected children with severe autoinflammation, resulting in the death of one sibling and allogeneic stem cell transplantation in the other two. All three were homozygous for MEFV p.S208C mutation; however, their phenotype was more severe than previously reported, prompting consideration of an oligogenic autoinflammation model. Further genetic studies revealed homozygous mutations in TRAP1, encoding the mitochondrial/ER resident chaperone protein tumour necrosis factor receptor associated protein 1 (TRAP1). Identification of a fourth, unrelated patient with autoinflammation and compound heterozygous mutation of TRAP1 alone facilitated further functional studies, confirming the importance of this protein as a chaperone of misfolded proteins with loss of function, which may contribute to autoinflammation. Impaired TRAP1 function leads to cellular stress and elevated levels of serum IL-18. This study emphasizes the importance of considering digenic or oligogenic models of disease in particularly severe phenotypes and suggests that autoinflammatory disease might be enhanced by bi-allelic mutations in TRAP1.


Subject(s)
HSP90 Heat-Shock Proteins/genetics , Hereditary Autoinflammatory Diseases/genetics , Mutation , Phenotype , Adolescent , Adult , Child , Child, Preschool , Consanguinity , Fatal Outcome , Female , Follow-Up Studies , Hematopoietic Stem Cell Transplantation/methods , Hereditary Autoinflammatory Diseases/blood , Hereditary Autoinflammatory Diseases/therapy , Humans , Infant , Infant, Newborn , Interleukin-18/blood , Male , Pedigree , Pyrin/genetics , Transplantation, Homologous , Treatment Outcome , Young Adult
8.
Mol Genet Genomic Med ; 6(6): 1243-1248, 2018 11.
Article in English | MEDLINE | ID: mdl-30328284

ABSTRACT

BACKGROUND: Early-onset Parkinson's disease (PD) is the most common inherited form of parkinsonism, with the PRKN gene being the most frequently identified mutated. Exon rearrangements, identified in about 43.2% of the reported PD patients and with higher frequency in specific ethnicities, are the most prevalent PRKN mutations reported to date in PD patients. METHODS: In this study, three consanguineous families with early-onset PD were subjected to whole-genome sequencing (WGS) analyses that were followed by Sanger sequencing and droplet digital PCR to validate and confirm the disease segregation of the identified genomic variations and to determine their parental origin. RESULTS: Five different PRKN structural variations (SVs) were identified. Because the genomic sequences surrounding the break points of the identified SVs might hold important information about their genesis, these were also characterized for the presence of homology and repeated sequences. CONCLUSION: We concluded that all identified PRKN SVs might originate through retrotransposition events.


Subject(s)
Genomic Structural Variation , Parkinson Disease/genetics , Ubiquitin-Protein Ligases/genetics , Adolescent , Adult , Female , Humans , Male , Middle Aged , Parkinson Disease/pathology , Retroelements
9.
Mol Neurobiol ; 55(8): 6734-6754, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29344929

ABSTRACT

This study aimed to gain insights into the pathophysiology underlying PLA2G6-associated neurodegeneration that is implicated in three different neurological disorders, suggesting that other, unknown genetic or environmental factors might contribute to its wide phenotypic expression. To accomplish this, we downregulated the function of pla2g6 in the zebrafish nervous system, performed parkinsonism-related phenotypic characterization, and determined the effects of gene regulation upon the loss of pla2g6 function by using RNA sequencing and downstream analyses. Pla2g6 deficiency resulted in axonal degeneration, dopaminergic and motor neuron cell loss, and increased ß-synuclein expression. We also observed that many of the identified, differentially expressed genes were implicated in other brain disorders, which might explain the variable phenotypic expression of pla2g6-associated disease, and found that top enriched canonical pathways included those already known or suggested to play a major role in the pathogenesis of Parkinson's disease. Our data support that pla2g6 is relevant for cranial motor development with significant implications in the pathophysiology underlying Parkinson's disease.


Subject(s)
Apoptosis , Axons/pathology , Brain/pathology , Dopaminergic Neurons/pathology , Group VI Phospholipases A2/deficiency , Nerve Degeneration/pathology , Zebrafish Proteins/deficiency , Zebrafish/metabolism , beta-Synuclein/metabolism , Animals , Apoptosis/drug effects , Axons/drug effects , Axons/metabolism , Base Sequence , Body Patterning/drug effects , Brain/drug effects , Brain/metabolism , Conserved Sequence , Dopaminergic Neurons/drug effects , Dopaminergic Neurons/metabolism , Down-Regulation/drug effects , Down-Regulation/genetics , Embryo, Nonmammalian/drug effects , Embryo, Nonmammalian/metabolism , Gene Expression Regulation, Developmental/drug effects , Group VI Phospholipases A2/genetics , Group VI Phospholipases A2/metabolism , Humans , Larva/drug effects , Larva/genetics , Larva/growth & development , Morpholinos/pharmacology , Motor Neurons/drug effects , Motor Neurons/metabolism , Motor Neurons/pathology , Phenotype , RNA, Messenger/genetics , RNA, Messenger/metabolism , Zebrafish/embryology , Zebrafish Proteins/genetics
10.
Neurobiol Aging ; 62: 244.e15-244.e17, 2018 02.
Article in English | MEDLINE | ID: mdl-29175279

ABSTRACT

A subset of early-onset Alzheimer's disease is inherited as an autosomal-dominant trait and is associated with mutations in the genes encoding ß-amyloid precursor protein, presenilin 1, or presenilin 2. In this study, we identified 2 PSEN1 mutations (1 novel and 1 known) in 2 unrelated Iranian families with autosomal-dominant Alzheimer's disease. The disease progressed rapidly with a mean age at onset of 33 and 42 years and an age at death ranging from 43 to 48 years.


Subject(s)
Alzheimer Disease/diagnosis , Alzheimer Disease/genetics , Genetic Association Studies , Genetic Testing , Mutation , Presenilin-1/genetics , Adult , Aged , Disease Progression , Female , Genes, Dominant/genetics , Humans , Iran , Male , Middle Aged
11.
Mol Neurobiol ; 55(4): 3477-3489, 2018 Apr.
Article in English | MEDLINE | ID: mdl-28502045

ABSTRACT

In this study, the role of known Parkinson's disease (PD) genes was examined in families with autosomal recessive (AR) parkinsonism to assist with the differential diagnosis of PD. Some families without mutations in known genes were also subject to whole genome sequencing with the objective to identify novel parkinsonism-related genes. Families were selected from 4000 clinical files of patients with PD or parkinsonism. AR inheritance pattern, consanguinity, and a minimum of two affected individuals per family were used as inclusion criteria. For disease gene/mutation identification, multiplex ligation-dependent probe amplification, quantitative PCR, linkage, and Sanger and whole genome sequencing assays were carried out. A total of 116 patients (50 families) were examined. Fifty-four patients (46.55%; 22 families) were found to carry pathogenic mutations in known genes while a novel gene, not previously associated with parkinsonism, was found mutated in a single family (2 patients). Pathogenic mutations, including missense, nonsense, frameshift, and exon rearrangements, were found in Parkin, PINK1, DJ-1, SYNJ1, and VAC14 genes. In conclusion, variable phenotypic expressivity was seen across all families.


Subject(s)
Family , Mutation/genetics , Parkinsonian Disorders/genetics , Adult , Amino Acid Sequence , Base Sequence , Exons/genetics , Female , Humans , Intracellular Signaling Peptides and Proteins , Male , Membrane Proteins/genetics , Middle Aged , Phosphoric Monoester Hydrolases/genetics , Protein Kinases/genetics , Ubiquitin-Protein Ligases/genetics , Young Adult
12.
Article in English | MEDLINE | ID: mdl-29123918

ABSTRACT

Hereditary spastic paraplegias are a rare group of clinically and genetically heterogeneous neurodegenerative diseases, with upper motor neuron degeneration and progressive lower limb spasticity as their main phenotypic features. Despite that 76 distinct loci have been reported and some casual genes identified, most of the underlying causes still remain unidentified. Moreover, a wide range of clinical manifestations is present in most hereditary spastic paraplegias subtypes, adding further complexity to their differential clinical diagnoses. Here, we describe the first exon rearrangement reported in the SPG45/SPG65 (NT5C2) loci in a family featuring a complex hereditary spastic paraplegias phenotype. This study expands both the phenotypic and mutational spectra of the NT5C2-associated disease.

13.
Neurol Genet ; 3(5): e177, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28808687

ABSTRACT

OBJECTIVE: Despite the enormous advancements made in deciphering the genetic architecture of Parkinson disease (PD), the majority of PD is idiopathic, with single gene mutations explaining only a small proportion of the cases. METHODS: In this study, we clinically evaluated 2 unrelated Spanish families diagnosed with PD, in which known PD genes were previously excluded, and performed whole-exome sequencing analyses in affected individuals for disease gene identification. RESULTS: Patients were diagnosed with typical PD without relevant distinctive symptoms. Two different novel mutations were identified in the CSMD1 gene. The CSMD1 gene, which encodes a complement control protein that is known to participate in the complement activation and inflammation in the developing CNS, was previously shown to be associated with the risk of PD in a genome-wide association study. CONCLUSIONS: We conclude that the CSMD1 mutations identified in this study might be responsible for the PD phenotype observed in our examined patients. This, along with previous reported studies, may suggest the complement pathway as an important therapeutic target for PD and other neurodegenerative diseases.

14.
Genet Test Mol Biomarkers ; 21(8): 485-490, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28723299

ABSTRACT

OBJECTIVE: The role of short tandem repeats (STRs) in the control of gene expression among species is being increasingly understood following the identification of several instances in which certain STRs occur identically, or expand differentially, in primates versus nonprimates. These STRs may regulate genes that participate in characteristics that are associated with the divergence of primates from sibling orders (e.g., brain higher order functions). The CYTH4 gene contains the longest tetranucleotide STR in its core promoter, at 7-repeats, and links to the evolution of human and nonhuman primates. Allele and genotype distribution of this STR were studied in patients affected by schizophrenia (SCZ) and controls. METHODS: High-resolution data were obtained on the allele and genotype distribution of the CYTH4 STR and a novel C > T single-nucleotide polymorphism (SNP) at its immediate upstream sequence in 255 patients with SCZ and 249 controls. Each sample was sequenced twice using the fluorescent dye termination method. RESULTS: Novel alleles were detected at the long extreme of the GTTT-repeat, at 10- and 11-repeats, in the SCZ cases and controls. Excess of homozygosity was observed for the entire range of alleles across the GTTT-repeat and the C > T SNP in the SCZ patients in comparison with the controls (Yates corrected p < 0.011). Three genotypes consisting of the 11-repeat allele (i.e., 11/11, 10/11, and 7/11) were detected only in the SCZ patients (i.e., disease-only genotypes), and contributed to 2.3% of the SCZ genotypes (Mid p exact <0.007). The frequency of the 11-repeat allele was estimated at 0.02 and 0.006 in the SCZ patients and controls, respectively (Mid p exact <0.006). CONCLUSION: This indicates that STR genotypes that are absent in the control group may be risk factors for SCZ. Future studies are warranted to test the significance of our findings.


Subject(s)
Cell Adhesion Molecules/genetics , Guanine Nucleotide Exchange Factors/genetics , Schizophrenia/genetics , Adult , Alleles , Case-Control Studies , Female , Genetic Association Studies/methods , Humans , Iran , Male , Microsatellite Repeats/genetics , Middle Aged , Polymorphism, Single Nucleotide/genetics , Promoter Regions, Genetic/genetics
15.
J Parkinsons Dis ; 7(3): 459-463, 2017.
Article in English | MEDLINE | ID: mdl-28671144

ABSTRACT

BACKGROUND: Common genetic variability in the ACMSD gene has been associated with increased risk for Parkinson's disease (PD) but ACMSD mutations in clinical cases of PD have so far not been reported. OBJECTIVE: To describe a case of sporadic PD carrying a novel ACMSD mutation. METHODS: As part of a genetic study to identify potential pathogenic gene defects related to PD in the Mediterranean island Menorca, an initial group of 62 PD patients underwent mutational screening using a panel-based sequencing approach. RESULTS: We report a 74-years-old man with sporadic PD who developed tremor in his right hand and slowness. On examination, moderate rigidity, asymmetric bradykinesia, and bilateral action tremor were present. He was started on levodopa with significant improvement. Two years later, he developed wearing off phenomena. The genetic study in the patient identified a novel ACMSD mutation resulting in p.Glu298Lys amino-acid change which was not present in neurologically normal population. CONCLUSIONS: Our data suggest that not only common genetic variability but also rare variants in ACMSD alone or in combination with other risk factors might increase the risk of PD.


Subject(s)
Carboxy-Lyases/genetics , Parkinson Disease/genetics , Aged , Genetic Predisposition to Disease , Humans , Male , Mutation
16.
Mov Disord ; 32(2): 287-291, 2017 02.
Article in English | MEDLINE | ID: mdl-27753167

ABSTRACT

INTRODUCTION: Atypical parkinsonism is a neurodegenerative disease that includes diverse neurological and psychiatric manifestations. OBJECTIVES: We aimed to identify the disease-cauisng mutations in a consanguineous family featuring intellectual disability and parkinsonism. METHODS: Full phenotypic characterization, followed by genome-wide single-nucleotide polymorphism genotyping and whole-genome sequencing, was carried out in all available family members. RESULTS: The chromosome, 2p23.3, was identified as the disease-associated locus, and a homozygous PTRHD1 mutation (c.157C>T) was then established as the disease-causing mutation. The pathogenicity of this PTRHD1 mutation was supported by its segregation with the disease status, its location in a functional domain of the encoding protein, as well as its absence in public databases and ethnicity-matched control chromosomes. CONCLUSION: Given the role of 2p23 locus in patients with intellectual disability and the previously reported PTRHD1 mutation (c.155G>A) in patients with parkinsonism and cognitive dysfunction, we concluded that the PTRHD1 mutation identified in this study is likely to be responsible for the phenotypic features of the family under consideration. © 2016 International Parkinson and Movement Disorder Society.


Subject(s)
Intellectual Disability/genetics , Membrane Proteins/genetics , Mitochondrial Proteins/genetics , Parkinsonian Disorders/genetics , Consanguinity , Genes, Recessive , Genome , Humans , Iran , Male , Pedigree , Polymorphism, Single Nucleotide
17.
Hum Mutat ; 37(11): 1180-1189, 2016 11.
Article in English | MEDLINE | ID: mdl-27449489

ABSTRACT

In this study, we described the identification of a large DNAJB2 (HSJ1) deletion in a family with recessive spinal muscular atrophy and Parkinsonism. After performing homozygosity mapping and whole genome sequencing, we identified a 3.8 kb deletion, spanning the entire DnaJ domain of the HSJ1 protein, as the disease-segregating mutation. By performing functional assays, we showed that HSJ1b-related DnaJ domain deletion leads to loss of HSJ1b mRNA and protein levels, increased HSJ1a mRNA and protein expressions, increased cell death, protein aggregation, and enhanced autophagy. Given the role of HSJ1 proteins in the degradation of misfolded proteins, we speculated that enhanced autophagy might be promoted by the elevated HSJ1a expression seen in HSJ1b-deficient cells. We also observed a significant reduction in both tau and brain-derived neurotrophic factor levels, which may explain the dopaminergic deficits seen in one of the affected siblings. We concluded that HSJ1b deficiency leads to a complex neurological phenotype, possibly due to the accumulation of misfolded proteins, caused by the lack of the DnaJ domain activity. We thus expand the phenotypic and genotypic spectrums associated with DNAJB2 disease and suggest relevant disease-associated mechanisms.


Subject(s)
HSP40 Heat-Shock Proteins/genetics , HSP40 Heat-Shock Proteins/metabolism , Molecular Chaperones/genetics , Molecular Chaperones/metabolism , Muscular Atrophy, Spinal/genetics , Parkinsonian Disorders/genetics , Sequence Deletion , Adult , Autophagy , Brain-Derived Neurotrophic Factor/metabolism , Chromosome Mapping , Down-Regulation , Female , Genetic Predisposition to Disease , Humans , Male , Muscular Atrophy, Spinal/metabolism , Parkinsonian Disorders/metabolism , Pedigree , Sequence Analysis, DNA , tau Proteins/metabolism
18.
Hum Mol Genet ; 24(24): 7111-20, 2015 Dec 15.
Article in English | MEDLINE | ID: mdl-26427606

ABSTRACT

Essential tremor (ET) is the most prevalent movement disorder, affecting millions of people in the USA. Although a positive family history is one of the most important risk factors for ET, the genetic causes of ET remain unknown. In an attempt to identify genetic causes for ET, we performed whole-exome sequencing analyses in a large Spanish family with ET, in which two patients also developed epilepsy. To further assess pathogenicity, site-directed mutagenesis, mouse and human brain expression analyses, and patch clamp techniques were performed. A disease-segregating mutation (p.Gly1537Ser) in the SCN4A gene was identified. Posterior functional analyses demonstrated that more rapid kinetics at near-threshold potentials altered ion selectivity and facilitated the conductance of both potassium and ammonium ions, which could contribute to tremor and increase susceptibility to epilepsy, respectively. In this report, for the first time, we associated the genetic variability of SCN4A with the development of essential tremor, which adds ET to the growing list of neurological channelopathies.


Subject(s)
Epilepsy/genetics , Essential Tremor/genetics , Genome, Human , Mutation , NAV1.4 Voltage-Gated Sodium Channel/genetics , Aged , Aged, 80 and over , Animals , Female , Humans , Male , Mice , Middle Aged , Sequence Analysis, DNA
19.
ASN Neuro ; 7(4)2015.
Article in English | MEDLINE | ID: mdl-26297037

ABSTRACT

*These authors contributed equally to this work.Essential tremor (ET) is the most prevalent movement disorder affecting millions of people in the United States. Although a positive family history is one of the most important risk factors for ET, the genetic causes of ET remain unknown. In this study, whole exome sequencing and subsequent approaches were performed in a family with an autosomal dominant form of early-onset ET. Functional analyses including mutagenesis, cell culture, gene expression, enzyme-linked immunosorbent, and apoptosis assays were also performed. A disease-segregating mutation (p.Gly171Ala), absent in normal population, was identified in the SORT1 gene. The p.Gly171Ala mutation was shown not only to impair the expression of its encoding protein sortilin but also the mRNA levels of its binding partner p75 neurotrophin receptor that is known to be implicated in brain injury, neuronal apoptosis, and neurotransmission.


Subject(s)
Adaptor Proteins, Vesicular Transport/genetics , Essential Tremor/genetics , Family Health , Mutation/genetics , Nerve Tissue Proteins/metabolism , Receptors, Nerve Growth Factor/metabolism , Up-Regulation/genetics , Adult , Aged , Aged, 80 and over , Apoptosis/genetics , Cohort Studies , DNA Mutational Analysis , Enzyme-Linked Immunosorbent Assay , Essential Tremor/physiopathology , Female , Flow Cytometry , HEK293 Cells , Humans , Male , Middle Aged , Nerve Tissue Proteins/genetics , Neurologic Examination , Neuropsychological Tests , RNA, Messenger , Receptors, Nerve Growth Factor/genetics , Surveys and Questionnaires , Transfection
20.
J Hum Genet ; 60(10): 637-40, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26134514

ABSTRACT

Although in the last two decades there has been considerable progress in understanding the genetic basis of Parkinson's disease (PD), the majority of PD is sporadic and its genetic causes are largely unknown. In an attempt to identify novel genetic causes of PD, whole-exome sequencing and subsequent analyses were performed in a family featuring late-onset PD with cognitive impairment. A novel genetic variant (p.Arg610Gly) in the GIGYF2 gene, previously known to be associated with PD, was identified as potential disease-causing mutation. The GIGYF2 p.Arg610Gly mutation situated in the GYF domain of the encoding protein was predicted to be pathogenic and to disrupt the GYF's ligand-binding abilities. Although further research is still required, this finding may shed light on the GIGYF2-associated mechanisms that lead to PD and suggests insulin dysregulation as a disease-specific mechanism for both PD and cognitive dysfunction.


Subject(s)
Carrier Proteins/genetics , Cognition Disorders/genetics , Exome , Mutation, Missense , Parkinson Disease/genetics , Amino Acid Substitution , Cognition Disorders/metabolism , Female , Humans , Male , Parkinson Disease/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...